A significant negative correlation between both Smad2 and Smad3 mRNA transcript levels and miR-1258 expression was also observed in 117 early stage HCC samples from the SYSUCC dataset (Fig. 2f). This evidence concerns the gene SMAD2 and hepatocellular carcinoma.